Smokeless Tobacco Products Pass FDA Marketing Test

The FDA is allowing new smokeless tobacco products to enter the US market.

The approval for 8 Swedish Match North America Inc snus smokeless tobacco products marks the first time that the FDA has authorized the marketing of a new tobacco product through the its premarket tobacco application pathway.

The goal of the pathway is to make sure that tobacco product marketing is appropriate for the protection of public health.

Among its considerations, the FDA analyzes the risks and benefits for both tobacco users and non-users. In addition, it reviews products’ components, ingredients, additives, health risks, and how the products were manufactured, packaged, and labeled.

The first orders were for the 8 Swedish Match North America Inc products under the General brand name.

After an analysis, the FDA determined that the company showed sufficient evidence that this marketing would lead to a low chance of new initiation, as well as a low likelihood of delayed smoking cessation or relapse.

“The FDA’s review also determined that these products would likely provide less toxic options if current adult smokeless tobacco users used them exclusively,” the FDA statement read.

While the tobacco products will be able to enter the US market, the FDA will continue to monitor the manufacturers’ marketing of the products. Information about advertising, sales, adverse effects, and information on current and new users will be sent to the FDA.

The FDA warned that it could withdraw the marketing order if the marketing was deemed no longer appropriate.

The company will not be able to say or imply that the products are FDA approved.

“All tobacco products are potentially harmful and addictive, and those who do not use tobacco products should continue to abstain from doing so,” the FDA wrote in its statement.